Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Huperzine-A for Cognitive Dysfunction and Functional Status in Schizophrenia

NCT01012830 is registered in ClinicalTrials.gov with VA Nebraska Western Iowa Health Care System as lead sponsor.

NCT NCT01012830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01012830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Huperzine-A for Cognitive Dysfunction and Functional Status in Schizophrenia
Lead sponsor
VA Nebraska Western Iowa Health Care System
Phase
Phase 4
Overall status
Unknown status
Start date
December 31, 2009
Completion date
April 30, 2011
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dementia, schizophrenia